CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-12 | Heffernan Michael Thomas Director | Sale | −27,920 | $22.01 | $615K | 28,023 |
| 2022-12-12 | Heffernan Michael Thomas Director | Option exercise · Stock Option (Right to Purchase) | −10,669 | 0 | ||
| 2022-12-12 | Heffernan Michael Thomas Director | Option exercise · Stock Option (Right to Purchase)t to | −15,741 | 0 | ||
| 2022-12-12 | Heffernan Michael Thomas Director | Option exercise · Stock Option (Right to Purchase) | −1,510 | 0 | ||
| 2022-12-02 | Ciaffoni Joseph President and CEO | Sale | −54,400 | $23.07 | $1.3M | 269,053 |
| 2022-12-01 | Ciaffoni Joseph President and CEO | Option exercise | +76,653 | $15.90 | $1.2M | 400,106 |
| 2022-12-01 | Ciaffoni Joseph President and CEO | Sale | −76,653 | $22.47 | $1.7M | 323,453 |
| 2022-12-01 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −76,653 | 0 | ||
| 2022-11-28 | Ciaffoni Joseph President and CEO | Option exercise | +43 | $15.90 | $684 | 323,496 |
| 2022-11-28 | Ciaffoni Joseph President and CEO | Sale | −43 | $22.00 | $946 | 323,453 |
| 2022-11-28 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −43 | 0 | ||
| 2022-11-22 | Ciaffoni Joseph President and CEO | Option exercise | +65 | $15.90 | $1K | 323,518 |
| 2022-11-22 | Ciaffoni Joseph President and CEO | Sale | −65 | $22.00 | $1K | 323,453 |
| 2022-11-22 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −65 | 0 | ||
| 2022-11-18 | Ciaffoni Joseph President and CEO | Option exercise | +1,989 | $15.90 | $32K | 325,442 |
| 2022-11-18 | Ciaffoni Joseph President and CEO | Sale | −1,989 | $22.02 | $44K | 323,453 |
| 2022-11-18 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −1,989 | 0 | ||
| 2022-10-04 | Tupper Colleen EVP & Chief Financial Officer | Sale | −4,350 | $17.35 | $75K | 90,304 |
| 2022-09-15 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −38,589 | $18.07 | $697K | 109,495 |
| 2022-08-11 | Kuhlmann Shirley R. EVP and General Counsel | Sale | −300 | $20.01 | $6K | 148,084 |
Page 14 of 24 · 462 trades